Amgen Inc. was founded in California in 1980 and became a Delaware corporation in 1987. The company discovers, develops, manufactures and delivers innovative medicines to fight some of the world's most intractable diseases. The company focuses on areas of high unmet medical needs and uses its expertise to strive for solutions that can significantly improve people's lives while reducing the social and economic burden of disease. The company helped launch the biotech industry more than 40 years ago and has grown into one of the world's leading independent biotech companies. 

Expected P&L on Expiry

Key Stats

Pricing Model

About AMGN20260327P350